# Effect of holoBLG on Cat Allergic Patients

> **NCT05455749** · NA · COMPLETED · sponsor: **Allergy Therapeutics** · enrollment: 42 (actual)

## Conditions studied

- Allergy to Cats
- Allergic Rhinoconjunctivitis

## Interventions

- **DIETARY_SUPPLEMENT:** holoBLG

## Key facts

- **NCT ID:** NCT05455749
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-04
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-03-16
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05455749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05455749, "Effect of holoBLG on Cat Allergic Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05455749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*